NIH-funded research R21 grant

Medication adherence to epilepsy medicines during pregnancy and related birth outcomes

Official title: Medication Adherence to Antiseizure Medications in Pregnancy and Associated Perinatal Outcomes

Funded at Vanderbilt University Medical Center · NIH-11454846 · Data updated 2026-11-12

This project looks at how well pregnant people with epilepsy take their anti-seizure medicines and what happens to their babies.

More Pregnancy research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 8, 2026
Project endSeptember 4, 2028
Funding year2026
Award (this year)$481,250
NIH project number1R21NS147342-01A1
Project IDNIH-11454846 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant individuals with epilepsy or those planning pregnancy who are taking antiseizure medications.

Less likely to help

People without epilepsy or not taking antiseizure medications during pregnancy are unlikely to benefit directly.

What this research studies

The study will use pharmacy data to map how consistently pregnant people with epilepsy take antiseizure medications. It aims to link adherence patterns with perinatal outcomes and safety concerns during pregnancy. Researchers plan to focus on women, including those in their first trimester, to understand how gaps in taking medicine may affect both mother and baby. The goal is to clarify whether risks come from the disease, the medications, or inconsistent use, to improve guidance for patients and clinicians.

Why it matters

Potential benefit: If successful, findings could lead to better strategies for maintaining safe medication use during pregnancy and improve birth outcomes for people with epilepsy.

How similar studies have gone: Previous work suggests adherence patterns influence outcomes, but many studies treat ASM exposure as a yes/no variable rather than continuous adherence.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Osmundson, Sarah Scheiderich — Vanderbilt University Medical Center
  • Study coordinator: Osmundson, Sarah Scheiderich

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.